GlassScriptPhysician profile
Arica Edwards
NPI 1831564400
$5,498.58
in general payments reported to CMS, 2019-2025
24 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,264 · 2022: $1,446 · 2023: $552 · 2024: $1,210 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,606 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,605.79 |
| Education | $182.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $964.34 | 2021-2025 | |
| Abbvie INC. | $728.59 | 2022-2025 | |
| Dermavant Sciences, INC. | $556.06 | 2023-2024 | Vtama |
| Galderma Laboratories, L.P. | $535.10 | 2021-2025 | Nemluvio, Epsolay, Aklief |
| Genzyme Corporation | $355.13 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $341.80 | 2021-2025 | Libtayo, Dupixent |
| Ucb, INC. | $287.10 | 2025 | Bimzelx |
| Incyte Corporation | $270.33 | 2022-2024 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $207.92 | 2024 | Sotyktu |
| Janssen Biotech, INC. | $194.88 | 2021 | |
| Vyne Pharmaceuticals INC. | $182.97 | 2021 | |
| Janssen Scientific Affairs, LLC | $180.53 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $166.41 | 2023-2025 | |
| Amgen INC. | $132.13 | 2021 | |
| Lilly USA, LLC | $102.35 | 2021-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $77.35 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $39.28 | 2021-2025 | |
| Leo Pharma INC. | $35.97 | 2021-2025 | Anzupgo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.97 | 2021-2025 | Cabtreo |
| Verrica Pharmaceuticals INC. | $27.35 | 2025 | Ycanth |
| Organon LLC | $25.49 | 2025 | Vtama |
| Medimetriks Pharmaceuticals, INC. | $19.40 | 2022 | |
| Arcutis Biotherapeutics, INC. | $19.38 | 2024 | Zoryve |
| Sun Pharmaceutical Industries INC. | $13.75 | 2023 | Winlevi, Absorica Ld |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arica Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.